• This fund invests primarily in equity securities of companies throughout the world which are involved in the design, manufacture, or sale of products and services used for or in connection with health care, medicine or biotechnology.
  • The fund is subject to investment, equities, foreign currency risk, holdings concentration and healthcare sector risk. The fund’s performance will be closely tied to the conditions in the European Economic Area, the fund may be subject to increased liquidity, price, and foreign exchange risk.
  • This fund can invest in derivative instruments which may involve additional risks (For example, leverage may cause greater volatility).
  • Investors may suffer substantial loss of their investments in the fund. Investor should not invest in the fund solely based on the information provided in this document and should read the prospectus (including potential risks involved) for details.

Fidelity Funds - Global Health Care Fund A-Euro

0.12%
0.05
  • Price date: 19/06/2018
  • Morningstar rating: 3 out of 5 stars
  • Risk rating+: 4

Performance & NAV

Annual performance Total return (%)

<span>Annual performance</span> Total return (%)
2017201620152014201320122011201020092008
4.33-10.2518.4037.8527.5613.572.4312.0421.39-21.16

Morningstar benchmark (%)

Morningstar benchmark (%)
2017201620152014201320122011201020092008
5.23-4.0318.7434.4830.3815.7313.119.5215.18-17.43

Cumulative return Fund (%)

<span>Cumulative return</span> Fund (%)
YTD6 mths1 yr3 yrs5 yrs
5.605.294.34-3.9772.15

Morningstar category (%)

Morningstar category (%)
YTD6 mths1 yr3 yrs5 yrs
5.596.246.11-1.6371.07

Morningstar benchmark (%)

Morningstar benchmark (%)
YTD6 mths1 yr3 yrs5 yrs
3.062.272.410.6779.45

As of 31/05/2018, based on latest unit NAV of most recent calendar month.

Fund details

Investment objective

The fund aims to provide investors with long-term capital growth, principally through investment in the equity securities of companies throughout the world which are involved in the design, manufacture, or sale of products and services used for or in connection with health care, medicine or biotechnology.

About this fund
Fund details as of31 May 2018
Denominated currencyEUR
Fund launch date01 Sep 2000
Class launch date01 Sep 2000
Class launch price20.00 EUR
Fund size626.91 million
IndexMSCI ACWI/Health Care NR USD
Morningstar BenchMarkMSCI World/Health Care NR USD
Morningstar CategorySector Equity Healthcare
Unique Identifiers
ISIN
LU0114720955
Bloomberg ticker
FIDHCFE LX
PhoneXpress code
1074
Fund manager
Fund manager
(Start date)
Hilary Natoff
(09 Jan 2006)
Alex Gold
(30 Jun 2017)
Fund Fees
Sale ChargesUp to 5.25%
Annual management feeUp to 1.50%

There are other fees and charges for the fund and please refer to the prospectus for details.

Volatility Measures
R-Squared
0.94
Beta
1.05
Alpha
-1.56
3 years standard deviation

As of 31/05/2018

13.86%
Risk rating

As of 28/02/2018

4
You may also be interested in
US stocks followed European and Asian stocks lower Tuesday as the US/China trade dispute escalated and in the process, weighed on shares and commodity prices. Late Monday, President Donald Trump threatened China with a further $200 billion in import tariffs if it did not drop plans to retaliate against US duties on imports that were revealed by the White House at the end of last week. The Dow Jones industrials were down 1.15 percent, the S&P retreated 0.4 percent and the Nasdaq slid 0.3 percent. The Dow is now negative for the year.
US stocks retreated as investors fretted over trade worries. The Dow Jones industrials were down 0.4 percent, the S&P slipped 0.2 percent and the Nasdaq was virtually unchanged. The weakness reflected worries about a global trade war after President Donald Trump announced plans to impose tariffs on $50 billion worth of Chinese goods last Friday, leading China to announce plans to impose tariffs on 545 products imported from the US. Traders worried the new tariffs could negatively affect global economic growth.

Data Source: Morningstar Asia Limited. The Morningstar sourced information is provided to investor(s) for reference purposes only. All fund prices quoted are calculated as at the latest valuation date. The performance information (%) in the chart and table may have slight variances due to factors such as rounding, or charting methodology used.

Past performance information is not indicative of future performance. Investors may not get back the full amount invested. Calculation of performance is based on the NAV-to-NAV for the stated period, with dividend reinvested, in denominated currency. These figures show by how much the share class increased or decreased in value during the stated period. Where no past performance is shown there was insufficient data available in that period to calculate performance.

Performance has been calculated in the “Denominated currency” set out in the “About this fund” section in the “Fund details” tab, including ongoing charges and excluding subscription fee and redemption fee you may have to pay.

Payments of dividends out of capital will only be made to seek to maintain a stable payment per share but the payment per share is not fixed. Dividend yield of the fund does not represent the return of the fund, and past dividend yield does not represent future dividend yield. The dividends are not guaranteed.

+

Fund risk ratings shown are calculated based on information as of #{hkweb.fundDetailService.getMaxRetailFundsRiskLevelAsOfDate}. Risk ratings are 1 = Low risk, 2 = Low to Medium risk, 3 = Medium risk, 4 = Medium to High risk, 5 = High risk. Fund risk ratings are generally reviewed on a semi-annual basis.

For more details on Fund risk ratings and its calculation methodology, please refer to the overview.

The fund risk rating is sourced from a methodology developed by Morningstar Investment Management Asia Limited and its affiliates. The fund risk rating is provided to investor(s) for reference purposes only.

^

Source: Fidelity.

^^

The name of the fund is not indicative of the fund’s performance and return.